Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Adam Koppel


  • Large Shareholder at Annexon Inc. (ANNX), 2020-07-28
  • Large Shareholder, Director at Aptinyx Inc. (APTX), 2020-07-02
  • Director at Solid Biosciences Inc. (SLDB), 2020-06-18
  • Director at Dicerna Pharmaceuticals Inc (DRNA), 2020-06-17
  • Large Shareholder at Arcutis Biotherapeutics Inc. (ARQT), 2020-02-06
  • Large Shareholder at Springworks Therapeutics Inc. (SWTX), 2019-09-19
  • Director at Replimune Group Inc. (REPL), 2018-07-26
  • Director at Trevena Inc (TRVN), 2018-05-17
  • Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2017-12-20
  • Director at Ptc Therapeutics Inc. (PTCT), 2017-01-06
  • Evp, Strategy And Bus. Dev. at Biogen Inc. (BIIB), 2016-06-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
APTX $3.00 3,333,333 Large Shareholder, Director 5,558,425 2020-01-14 Filing
APTX $16.00 400,000 Director 2,225,092 2018-06-25 Filing
SLDB $16.00 300,000 Director 1,989,444 2018-01-30 Filing
PTCT $15.00 1,250,000 Director 2,333,333 2013-06-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DRNA $24.68 1,500,000 Director 4,080,237 2019-12-04 Filing
BIIB $290.00 555 Officer 2,402 2016-06-06 Filing
BIIB $275.00 102 Officer 1,848 2016-04-06 Filing